Production (Stage)
Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.09
-$0.15-12.10%
OTC PK
| 03/31/2025 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -7.17% | 22.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.17% | 22.96% | |||
| Cost of Revenue | -6.55% | 6.58% | |||
| Gross Profit | -7.53% | 33.91% | |||
| SG&A Expenses | -14.91% | 45.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 90.77% | -102.35% | |||
| Total Operating Expenses | -8.99% | 21.96% | |||
| Operating Income | 0.01% | 27.00% | |||
| Income Before Tax | 15.03% | 403.03% | |||
| Income Tax Expenses | 15.79% | -10.56% | |||
| Earnings from Continuing Operations | 14.72% | 728.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.72% | 728.30% | |||
| EBIT | 0.01% | 27.00% | |||
| EBITDA | -2.41% | 33.25% | |||
| EPS Basic | 15.74% | 721.62% | |||
| Normalized Basic EPS | 17.74% | 412.82% | |||
| EPS Diluted | 15.74% | 721.62% | |||
| Normalized Diluted EPS | 17.74% | 412.82% | |||
| Average Basic Shares Outstanding | -0.87% | 1.49% | |||
| Average Diluted Shares Outstanding | -0.87% | 1.49% | |||
| Dividend Per Share | -- | 5.36% | |||
| Payout Ratio | -0.09% | 1.16% | |||